Lazzeri Chiara, Bonizzoli Manuela, Ghinolfi Davide, Li Marzi Vincenzo, Luzzi Luca, Entani Santini Lara, Peris Adriano
Regional Center for Transplant Coordination, Florence, Italy -
Intensive Care Unit, ECMO Referral Center, Florence, Italy.
Minerva Anestesiol. 2025 Mar;91(3):184-190. doi: 10.23736/S0375-9393.25.18475-7.
Uncontrolled DCD (uDCD) represents a potential source of organs since the global survival rates of patients with out of hospital cardiac arrest (OHCA) is estimated less than 10% across all registries. We describe our 8-year experience with the implementation of the uDCD program over the Tuscany Region since June 2016. We focus on feasibility, results (organ transplant) and organizational changes.
The study population included uDCDs assessed in the Tuscany Region from 2016 to 2024. Two different periods were considered: Period 1: from 2016 to 2019; Period 2: from 2020 to 2024 (after COVID pandemic).
Overall, 226 potential uDCDs were assessed by the local transplant coordinators, with an increased number in Period 2 in respect to Period 1 (151 vs. 75, 67% vs. 33%). A significant increase in refusals was observed (Period 2: 25% vs. Period 1: 6%, P=0.004). The overall utilization rate was 56%. Fifty-seven kidneys were transplanted, 22 livers and two lungs. The number of organs per donor increased in Period 2 compared to Period 1.
According to our 8-year experience, the uDCD proved to be an add-on activity, giving the opportunity to all OHCA patients without survival options to save lives by organ donation. The uDCD only lung program is a feasible chance to organ donate for OHCA patients with no survival possibility in peripheral hospital. The uDCD program, despite its complexity, seems to have potentials ranging to organizational (uDCD only lung program, mobile machine perfusion) to clinical issues (optimizing the donor-recipient match).
由于所有登记处估计院外心脏骤停(OHCA)患者的全球生存率低于10%,未控制的心脏死亡器官捐献(uDCD)是一个潜在的器官来源。我们描述了自2016年6月以来在托斯卡纳地区实施uDCD项目的8年经验。我们关注可行性、结果(器官移植)和组织变革。
研究人群包括2016年至2024年在托斯卡纳地区评估的uDCD。考虑了两个不同时期:时期1:2016年至2019年;时期2:2020年至2024年(新冠疫情之后)。
总体而言,当地移植协调员评估了226例潜在的uDCD,时期2的数量相对于时期1有所增加(151例对75例,67%对33%)。观察到拒绝率显著增加(时期2:25%对时期1:6%,P = 0.004)。总体利用率为56%。移植了57个肾脏、22个肝脏和2个肺。与时期1相比,时期2每个供体的器官数量增加。
根据我们8年的经验,uDCD被证明是一项附加活动,为所有没有生存选择的OHCA患者提供了通过器官捐献拯救生命的机会。uDCD单肺项目是为外周医院没有生存可能的OHCA患者进行器官捐献的可行机会。uDCD项目尽管复杂,但似乎具有从组织层面(uDCD单肺项目、移动机器灌注)到临床问题(优化供体-受体匹配)等多方面的潜力。